FDA Clears AI-Powered Module for Detecting Hemispheric Subdural Hematomas on CT
The Rapid SDH module on the RapidAI platform reportedly offers a sensitivity rate of 93 percent for detection of hemispheric subdural hematoma on non-contrast computed tomography (CT) scans.
The Food and Drug Administration (FDA) has granted 510(k) clearance for RapidAI’s Rapid SDH, an artificial intelligence (AI)-enabled module that reportedly notifies radiologists of suspected hemispheric subdural hematomas within one minute of reviewing a computed tomography (CT) scan.
For suspected acute and chronic hemispheric subdural hematomas > 1 mL, the Rapid SDH module offers a sensitivity rate of 93 percent and a specificity rate of 99 percent, according to RapidAI.
In addition to flagging suspected cases of hemispheric subdural hematomas, RapidAI said the Rapid SDH module facilitates multidisciplinary collaboration for the management of these patients via automated notification sent via the RapidAI app, PACS and e-mail.
"The FDA's clearance of Rapid SDH significantly enhances our expanding range of hemorrhagic and trauma care solutions at this crucial time of rapidly growing patient numbers, clinician shortages, and advancements in potential treatment options,” said Amit Phadnis, the chief innovation and technology officer of RapidAI. “Our goal is to continue to expand the capabilities and applications of our deep AI to deliver comprehensive clinical solutions that provide care teams with the crucial insights necessary to evaluate patients, streamline decision making, and expedite care for this common and dangerous disease.”
Recent Videos
Related Content
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025Article
For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
Study Suggests AI Software May Offer Standalone Value for X-Ray Detection of Pediatric Fractures
April 9th 2025Article
Artificial intelligence (AI) software demonstrated a 92 percent sensitivity for detecting fractures in a study involving over 1,600 X-rays from a tertiary pediatric emergency department.
FDA Clears AI Assessment of Ischemic Core Volume on CT with Brainomix 360 Platform
April 8th 2025Article
For patients with acute ischemic stroke, research has demonstrated that automated assessment of ischemic core volume on brain CT scans via the Brainomix 360 software is equivalent to that derived from CT perfusion.
